SBI Contra Fund (G)
NAV as on 17 Aug, 2017
SNAPSHOT
Performance
Investment Info
Peers
Portfolio
News and Videos
Below average performance in the category
The scheme is ranked 4 in Diversified Equity category by Crisil (for quarter ended Jun 2017) rank unchanged from last quarter. If you are already invested in this scheme, you may consider switching to a better performing scheme.
Returns (NAV as on 17 Aug, 2017)
| Period | Returns (%) | Rank # |
|---|---|---|
| 1 mth | -2.5 | 217 |
| 3 mth | 2.0 | 123 |
| 6 mth | 13.3 | 89 |
| 1 year | 13.6 | 167 |
| 2 year | 8.8 | 163 |
| 3 year | 13.0 | 126 |
| 5 year | 15.8 | 54 |
# Moneycontrol Rank within 261 Diversified Equity Schemes.
Absolute Returns (in %)
| Year | Qtr 1 | Qtr 2 | Qtr 3 | Qtr 4 | Annual |
|---|---|---|---|---|---|
| 2017 | 14.4 | 5.0 | - | - | - |
| 2016 | -2.4 | 7.7 | 6.1 | -10.2 | 1.8 |
| 2015 | 5.1 | -4.8 | -2.1 | -0.1 | -0.5 |
| 2014 | 7.2 | 16.5 | 7.3 | 9.5 | 47.5 |
| 2013 | -4.2 | -3.2 | -7.1 | 10.8 | -2.3 |
| 2012 | 17.5 | -2.9 | 7.1 | 6.4 | 33.4 |
* Returns over 1 year are Annualised
* Calculation Remark - Dividends are reinvested at the rate of return
Performance
Fund returns v/s Category average (Diversified Equity)
| 1 mth (%) | 3 mth (%) | 6 mth (%) | 1 yr (%) | 2 yr (%) | 3 yr (%) | 5yr (%) | |
| Fund Returns | -2.5 | 2.0 | 13.3 | 13.6 | 8.8 | 13.0 | 15.8 |
| Category avg | -0.2 | 1.6 | 10.3 | 15.6 | 9.7 | 10.6 | 10.1 |
| Difference of Fund returns and Category returns | -2.3 | 0.4 | 3.0 | -2.0 | -0.9 | 2.4 | 5.7 |
| Best of category | 7.5 | 16.9 | 21.3 | 32.7 | 25.4 | 42.5 | 28.4 |
| Worst of category | -8.8 | -7.7 | -18.5 | -19.0 | -7.5 | -1.7 | 1.4 |
| Benchmark returns # | 0.1 | 3.9 | 12.6 | 16.1 | 9.2 | 8.9 | 13.9 |
| Difference of Fund returns and Benchmark returns | -2.6 | -1.9 | 0.7 | -2.5 | -0.4 | 4.1 | 1.9 |
Investment Info
Investment Objective
To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy. There are five sub-funds dedicated to specific investment themes viz Information Technology, Pharmaceuticals,FMCG, Contrarian (investment in stocks currently out of favour) and Emerging Businesses.
Scheme details
| Fund Type | Open-Ended |
|---|---|
| Investment Plan | Growth |
| Launch date | Jul 31, 1999 |
| Benchmark | S&P BSE 100 |
| Asset Size (Rs cr) | 1,663.29 (Mar-31-2017) |
| Minimum Investment | Rs.5000 |
| Last Dividend | Rs.2.10 (Nov-09-2004) View Dividend History |
| Bonus | N.A. |
| Fund Manager | R. Srinivasan View performance of schemes managed by the Fund Manager |
| Notes | N.A |
Load Details
| Entry Load | N.A |
|---|---|
| Exit Load | 1.00% |
| Load Comments | Exit Load 1% if units are redeemed / switched-out within 1 year from the date of allotment. |
Contact Details
| Regd. Office | 191 Maker Towers E, Cuffe Parade, Mumbai, 400005 |
|---|---|
| Tel. No. | 91 22 22180221/ 27 |
| Fax No. | 91 22 22189663 |
| partnerforlife@sbimf.com | |
| Website | http://www.sbimf.com |
Peer Comparison
| Diversified Equity | Crisil Rank | Assets (Rs.cr) |
|||||
| 3mth (%) | 6mth (%) | 1yr (%) | 3yr (%) | 5yr (%) | |||
| Franklin (I) Prima Plus -Direct (G) | Rank 3 |
1,704.47 | 3.3 | 11.0 | 16.5 | 18.1 | -- |
| Franklin India Prima Plus (G) | Rank 3 |
8,479.15 | 3.1 | 10.4 | 15.2 | 16.7 | 20.1 |
| Reliance Equity Oppor - RP (G) | Rank 5 |
8,662.40 | -0.1 | 12.3 | 14.0 | 11.8 | 17.1 |
| ICICI Pru Value Discovery Fund (G) | Rank 4 |
14,011.22 | 0.2 | 6.7 | 10.5 | 13.5 | 21.7 |
| HDFC Equity Fund - Direct (G) | Rank 3 |
3,971.06 | 1.7 | 14.2 | 22.4 | 12.6 | -- |
| * Returns over 1 year are Annualised | More » | ||||||
Portfolio
Top Holdings (Jul 31, 17)
| Equity | Sector | Value (Rs cr) |
Asset % |
|---|---|---|---|
| SBI | Banking/Finance | 146.88 | 7.98 |
| HDFC Bank | Banking/Finance | 140.97 | 7.66 |
| P and G | Cons NonDurable | 104.55 | 5.68 |
| ICICI Bank | Banking/Finance | 99.86 | 5.43 |
| Divis Labs | Pharmaceuticals | 81.67 | 4.44 |
| Elgi Equipments | Engineering | 78.01 | 4.24 |
| Kotak Mahindra | Banking/Finance | 71.52 | 3.89 |
| Reliance | Oil & Gas | 64.61 | 3.51 |
| HCL Tech | Technology | 62.50 | 3.40 |
| Aurobindo Pharm | Pharmaceuticals | 55.33 | 3.01 |
Sector Allocation (Jul 31, 17)
| Sector | % | 1-Year HighLow |
|
|---|---|---|---|
| Banking/Finance | 39.24 | 0.00 | 0.00 |
| Engineering | 10.29 | 0.00 | 0.00 |
| Pharmaceuticals | 7.45 | 0.00 | 0.00 |
| Automotive | 6.20 | 0.00 | 0.00 |
| Cons NonDurable | 5.68 | 0.00 | 0.00 |
| Services | 4.62 | 0.00 | 0.00 |
Asset Allocation (%)(Jul 31, 17)
| Equity | 91.45 |
| Others | 4.37 |
| Debt | 0.00 |
| Mutual Funds | N.A |
| Money Market | 4.69 |
| Cash / Call | -0.51 |
Concentration
| Holdings | (%) |
|---|---|
| Top 5 | 31.19 |
| Top 10 | 49.24 |
| Sector | (%) |
|---|---|
| Top 3 | 56.98 |
News & Videos
News
India can be an oasis of hope among emerging markets: SBI MF
Navneet Munot, CIO, SBI Mutual Fund says it's yet early days but India could be an ‘oasis of hope ...
Jun 27, 2016 at 11:50 | Source: CNBC-TV18
-
Bull market correction on; time to invest for long-term: Pros
Long-term investors should be looking at opportunities rather than being worried about what is happe ...
Jan 16, 2016 at 15:28 | Source: CNBC-TV18
-
Mutual Funds bullish on EPFO move to invest in equity funds
The government's decision to allow Employees' Provident Fund Organisation (EPFO) invest 5 percent of ...
Jul 17, 2015 at 22:19 | Source: PTI
Messages & Community
Quick Links
